ASGCT Policy Summit

November 4 – 6 | The Westin City Center | Washington, D.C.

Registration Open Now

Daily registration allows Policy Summit attendees to choose the legislative, regulatory, and bioethical content that's most relevant to them, or to register for all three days for a full-scope experience. Registration closes on October 28.

Daily Schedules and Opportunities

Global Regulatory Issues in Gene Therapy Development

November 4: Explore solutions to challenges experienced both by global regulators and by sponsors developing gene therapies across established and emerging markets.

Perspectives on Payment Policies for Gene Therapies

November 5: Address the status of legislative and regulatory solutions to the primary challenges in paying for gene therapies for different payer types, as well as the current state of Medicaid reimbursement policies for these therapies.

Ethical, Societal, and Policy Issues in Germline Gene Editing

November 6: Stakeholders discuss considerations surrounding germline gene editing, including current legal status for clinical research; recent proposals to limit clinical applications; and potential mechanisms necessary to achieve societal consensus.


Take advantage of ASGCT's daily registration to tailor your Policy Summit experience to your expertise, or register for all three days and take in the full scope of regulatory, payment, and bioethical issues surrounding gene and cell therapy. Registration closes on October 28.

Policy Summit Sponsorship

Support leaders in the scientific, regulatory, and bioethical communities by partnering with ASGCT to sponsor the ASGCT Policy Summit.


ASGCT Policy Summit

November 4 – 6 | Washington D.C.